Lu Guo

PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study

Ke Su, Lu Guo, Wenqiong Ma et al. · Frontiers in Immunology · 2022 · 52 citations · Full text

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

Ke Su, Lu Guo, Kun He et al. · Frontiers in Oncology · 2022 · 45 citations · Full text

Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study

Ke Su, Pan Wang, Kun He et al. · Hepatology International · 2022 · 42 citations · Full text

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

Han Li, Lu Guo, Ke Su et al. · Journal of Hepatocellular Carcinoma · 2023 · 42 citations · Full text

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

Ke Su, Weihong Huang, Xueting Li et al. · Journal of Hepatocellular Carcinoma · 2023 · 40 citations · Full text